Group One Trading
IMVT icon

Group One Trading’s Immunovant IMVT Stock Holding History

Group One Trading’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,500
Closed -$1.26M – 8132
2025
Q4 		$1.26M Sell
49,500
-24,300
-33% -$542K ﹤0.01% 2692
2025
Q3 		$1.19M Sell
73,800
-4,200
-5% -$68K ﹤0.01% 2852
2025
Q2 		$1.25M Sell
78,000
-343,500
-81% -$5.19M ﹤0.01% 2564
2025
Q1 		$7.2M Buy
421,500
+50,900
+14% +$1.06M 0.02% 814
2024
Q4 		$9.18M Buy
370,600
+9,000
+2% +$255K 0.02% 758
2024
Q3 		$10.3M Buy
361,600
+329,200
+1,016% +$9.71M 0.03% 604
2024
Q2 		$855K Buy
32,400
+26,100
+414% +$742K ﹤0.01% 2128
2024
Q1 		$204K Sell
6,300
-112,800
-95% -$4.12M ﹤0.01% 3549
2023
Q4 		$5.02M Sell
119,100
-445,900
-79% -$16.4M 0.01% 1137
2023
Q3 		$21.7M Buy
565,000
+484,800
+604% +$11M 0.07% 206
2023
Q2 		$1.52M Buy
80,200
+8,000
+11% +$149K ﹤0.01% 1969
2023
Q1 		$1.12M Sell
72,200
-69,800
-49% -$1.21M ﹤0.01% 2040
2022
Q4 		$2.52M Sell
142,000
-58,900
-29% -$742K 0.01% 1637
2022
Q3 		$1.12M Sell
200,900
-31,200
-13% -$153K ﹤0.01% 2455
2022
Q2 		$905K Sell
232,100
-383,200
-62% -$1.66M ﹤0.01% 2852
2022
Q1 		$3.39M Sell
615,300
-707,500
-53% -$4.41M ﹤0.01% 1875
2021
Q4 		$11.3M Buy
1,322,800
+800
+0.1% +$6.6K 0.01% 1017
2021
Q3 		$11.5M Buy
1,322,000
+560,000
+73% +$5.05M 0.01% 972
2021
Q2 		$8.05M Buy
762,000
+751,000
+6,827% +$10.5M 0.01% 1255
2021
Q1 		$176K Buy
+11,000
New +$290K ﹤0.01% 5152

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Group One Trading's IMVT Position: Q1 2026 in Review

Group One Trading increased its Immunovant (IMVT) stake by 356% in Q1 2026, buying an estimated $416K and bringing the position to 20,586 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #3325.

Group One Trading first reported a position in IMVT in Q1 2021 and has held it in 17 quarters since. The position peaked at $5.79M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Group One Trading held 20,586 shares of Immunovant worth $511K as of Q1 2026.
  • Group One Trading bought 16,074 Immunovant shares in Q1 2026, an estimated $416K.
  • Immunovant made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3325 holding.
  • Group One Trading first reported a position in Immunovant in Q1 2021 and has held it in 17 quarters since.
  • Group One Trading's Immunovant position peaked at $5.79M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.